Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 3/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.39 |
| ▸ | RELA | Q04206 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | DNTT | P04053 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HLCS | P50747 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1614688 | 0.98 | CYP1A2 (0.39) | NFKB1NFKB2RELACYP1A2PPARG | |
| SCHEMBL27482176 | 0.98 | CYP1A2 (0.39) | NFKB1NFKB2RELACYP1A2PPARG | |
| SCHEMBL27609553 | 0.94 | NFKB1 (0.44) | NFKB1NFKB2RELACYP1A2PPARG | |
| SCHEMBL14127829 | 0.89 | NFKB1 (0.37) | NFKB1NFKB2RELACYP1A2PPARG | |
| SCHEMBL6439905 | 0.86 | — | — | |
| SCHEMBL6440802 | 0.77 | — | — | |
| SCHEMBL2777191 | 0.76 | NFKB1 (0.41) | NFKB1NFKB2RELACYP1A2ALDH1A1 | |
| SCHEMBL11766874 | 0.73 | NFKB1 (0.41) | NFKB1NFKB2RELACYP1A2PPARG | |
| SCHEMBL7516212 | 0.69 | CYP1A2 (0.40) | NFKB1NFKB2RELACYP1A2PPARG | |
| SCHEMBL9618293 | 0.69 | CYP1A2 (0.44) | CYP1A2PPARGDNTTGRM2SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-114349640-B | Synthesis method of methyl dihydrojasmonate or intermediate thereof and catalyst used in synthesis method | 山东新和成药业有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-114349640-A | Synthesis method of methyl dihydrojasmonate or intermediate thereof and catalyst used in synthesis method | 山东新和成药业有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-110590524-A | Method for preparing amyl cyclopentenone without isomerization of organic solvent in synthesis of methyl dihydrojasmonate | 万香科技股份有限公司 | 2019-12-20 | — | — | CN | claimed |
| CN-106083575-A | A kind of preparation method of n-propyl dihydro-jasmonate | 郑州卓越农业科技有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-104628565-A | Synthetic method for MDJ (Methyl Dihydrojasmonate) | UNIV ANHUI SCI & TECHNOLOGY | 2015-05-20 | — | — | CN | claimed |
| CN-103058840-A | Synthetic method of michelia alba diketone | HUAIAN WANBANG AROMATIC CHEMICALS INDUSTRY CO LTD | 2013-04-24 | — | — | CN | claimed |
| CN-101429122-B | Decarboxylation method used in synthesis of methyl dihydrojasmonate | HUAIAN WANBANG AROMATIC CHEMICALS CO LTD | 2012-03-21 | — | — | CN | claimed |
| CN-101519355-B | Method for preparing methyl dihydrojasmonate | NORTHWEST NORMAL UNIVERSITY (CN) | 2011-11-30 | — | — | CN | claimed |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | KAO CORPORATION (JP) | 2010-09-30 | — | — | US | claimed |
| CN-101802189-A | Beta-glucuronidase inhibitor | KAO CORP | 2010-08-11 | — | — | CN | claimed |
| EP-2192178-A1 | B-GLUCURONIDASE INHIBITOR | Kao Corporation (JP) | 2010-06-02 | — | — | EP | claimed |
| CN-101519355-A | Method for preparing methyl dihydrojasmonate | UNIV NORTHWEST NORMAL | 2009-09-02 | — | — | CN | claimed |
| CN-101429122-A | Decarboxylation method used in synthesis of methyl dihydrojasmonate | HUAIAN WANBANG AROMATIC CHEMIC (CN) | 2009-05-13 | — | — | CN | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| JP-59084843-A | — | — | None | — | — | JP | disclosed |
| US-3981891-A | PERFUMES, COSMETICS | SOCIETE ANONYME ROURE BERTRAND DUPONT (FR) | 1976-09-21 | — | — | US | disclosed |
| US-3951876-A | Odoriferous compositions containing certain cyclopentanone derivatives | SOCIETE ANONYME DES ETABLISSEMENTS ROURE-BERTRAND FILS & JUSTIN DUPONT (FR) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | GUSB, GAA, GANAB | NFKB1 2035/4885NFKB2 2296/4885RELA 3102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.